Ann: CEO Presentation to Bioshares Conference, page-7

great slides about deals in the wound care space and also the previous clinical trials and results.

CB during his roadshow a couple of years ago made reference to a 5-7 appreciation in market cap (from $45-50m) pending good trial readout.

Marc Sinatra has placed a deal size around the same market

both of which are very consistent the deals listed in this preso.

they seem to have done their homework from the start (of the restructured company). and we are getting closer and closer to the readout.

exciting times! (as long as the trial is a success)

but all the graphs released to date are certainly positive to the extent that you can extrapolate and compare against historical benchmark data...

what you can pretty mIch guarantee Is Its not goIng back to 4.2c prIor to readout...